Bokf Na Reduces Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Bokf Na lowered its position in DocuSign, Inc. (NASDAQ:DOCU) by 5.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,064 shares of the company’s stock after selling 763 shares during the quarter. Bokf Na’s holdings in DocuSign were worth $645,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Massmutual Trust Co. FSB ADV increased its position in shares of DocuSign by 5,000.0% in the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $27,000 after buying an additional 500 shares in the last quarter. Mather Group LLC. increased its position in shares of DocuSign by 4,338.5% in the second quarter. Mather Group LLC. now owns 577 shares of the company’s stock valued at $31,000 after buying an additional 564 shares in the last quarter. Register Financial Advisors LLC purchased a new position in shares of DocuSign in the first quarter valued at $37,000. ICA Group Wealth Management LLC purchased a new stake in DocuSign during the 4th quarter worth about $39,000. Finally, nVerses Capital LLC purchased a new stake in DocuSign during the 2nd quarter worth about $48,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insiders Place Their Bets

In other DocuSign news, Director Daniel D. Springer sold 287,052 shares of DocuSign stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the sale, the director now directly owns 923,445 shares in the company, valued at approximately $49,662,872.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Daniel D. Springer sold 287,052 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total value of $15,437,656.56. Following the completion of the sale, the director now directly owns 923,445 shares in the company, valued at approximately $49,662,872.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 49,123 shares of the business’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $51.15, for a total value of $2,512,641.45. Following the completion of the sale, the chief financial officer now owns 70,473 shares of the company’s stock, valued at $3,604,693.95. The disclosure for this sale can be found here. Insiders have sold 480,618 shares of company stock worth $25,432,336 in the last three months. 1.66% of the stock is owned by insiders.

DocuSign Stock Performance

DocuSign stock opened at $56.63 on Monday. The stock’s 50 day moving average price is $55.57 and its 200 day moving average price is $56.09. The firm has a market capitalization of $11.59 billion, a PE ratio of 108.90, a price-to-earnings-growth ratio of 5.99 and a beta of 0.93. DocuSign, Inc. has a one year low of $38.11 and a one year high of $64.76.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The company had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. During the same period in the previous year, the business earned $0.09 EPS. DocuSign’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, analysts forecast that DocuSign, Inc. will post 0.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DOCU has been the subject of a number of recent research reports. Morgan Stanley dropped their price objective on DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a research report on Friday, June 7th. Bank of America raised their price target on DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Robert W. Baird lifted their price objective on DocuSign from $55.00 to $59.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Piper Sandler reduced their price objective on DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a research note on Friday, June 7th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, September 6th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $61.45.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.